Vanrx Pharmasystems

Vanrx Pharmasystems

Vanrx Pharmasystems manufactures aseptic filling machines that improve the production of sterile injectables.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k
Notes (0)
More about Vanrx Pharmasystems
Made with AI
Edit

Vanrx, now part of Cytiva, specializes in developing advanced aseptic filling machines known as Aseptic Filling Workcells. These machines are designed to fill vials, syringes, and cartridges with biopharmaceutical products in a sterile environment, ensuring the safety and efficacy of the drugs. Vanrx serves clients in the biopharmaceutical industry, including major companies like Roche Genentech, Moderna, and FUJIFILM Diosynth. The company operates in the biopharma manufacturing market, focusing on providing flexible and automated solutions that meet the unique needs of modern therapeutics. Vanrx's business model revolves around selling these high-tech filling machines and offering related services, generating revenue through equipment sales and maintenance contracts. The company's innovative technology helps reduce risks and speeds up the time-to-market for new drugs, making it a valuable partner for biopharma companies aiming to bring their products to patients faster.

Keywords: Aseptic Filling, Biopharma, Vials, Syringes, Cartridges, Automation, Flexibility, Drug Delivery, Sterile Manufacturing, Therapeutics.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo